Enterobacter cloacae in a haematology/oncology ward--first impressions.
The observation that Enterobacter cloacae has emerged as a cause of infection in a haematology/oncology ward prompted a prospective study over an eight-month period. Sensitivity to antibiotics, plasmid screening and typing methods were used to describe the epidemiology of the organism which was isolated from 22 patients. There was evidence of a limited amount of cross infection. No common sources were found. A large number of distinct strains were identified. E. cloacae infection was associated with prolonged profound leucopenia and broad-spectrum antibiotic therapy.
McConkey
S J
SJ
Trinity College Dublin Medical School, St. James's Hospital, Ireland.
Coleman
D C
DC
Falkiner
F R
FR
McCann
S R
SR
Daly
P A
PA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D015373:Bacterial Typing Techniques; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology*; D004352:Drug Resistance, Microbial; D004754:Enterobacter / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006405:Hematology; D006757:Hospital Units; D006801:Humans; D007494:Ireland; D008297:Male; D008495:Medical Oncology; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications; D011446:Prospective Studies
D000900:Anti-Bacterial Agents